ImmuCell Corp (ICCC) KPIs and segments
Close on Nov 13, 2026Market cap $97.63MP/E 53.8Yield –
KPIs & segments
Operating metrics and segments that drive ImmuCell's business
ImmuCell's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Corporate Segment, Scours($M) | 7.11 | 10.3 | 7.58 | 5.44 | 6.40 | 8.03 | 7.71 | 5.95 | |||||
Scours($M) | 6.40 | 8.03 | 7.71 | 5.95 | 5.43 | 7.22 | 5.04 | 5.36 | |||||
Corporate Segment, Mastitis($M) | 0.08 | 0.05 | 0.05 | 0.06 | 0.05 | 0.04 | 0.04 | 0.06 | |||||
Mastitis($M) | 0.05 | 0.04 | 0.04 | 0.06 | 0.04 | 0.04 | 0.06 | 0.04 | |||||
First Defense product line($M) | 6.40 | 8.03 | 7.71 | 5.95 | 5.43 | 7.22 | 5.04 | 5.36 | |||||
Other animal health($M) | 0.05 | 0.04 | 0.04 | 0.06 | 0.04 | 0.04 | 0.06 | 0.04 | |||||
United States($M) | 4.87 | 7.17 | 6.44 | 5.22 | 4.89 | 6.34 | 4.78 | 4.92 | |||||
Other($M) | 1.57 | 0.89 | 1.31 | 0.80 | 0.58 | 0.92 | 0.32 | 0.47 | |||||
Scours($M) | 2.08 | 2.47 | 2.04 | 0.83 | 0.31 | 1.60 | 0.67 | 0.62 | |||||
Corporate Segment, Mastitis($M) | 2.07 | -0.16 | -0.82 | -0.64 | -0.76 | -0.70 | -0.81 | -0.84 | |||||
Corporate Segment, Scours($M) | 1.17 | 3.32 | 1.92 | 1.42 | 2.08 | 2.47 | 2.04 | 0.83 | |||||
Other($M) | -0.75 | -0.66 | -0.61 | -0.57 | -0.64 | -0.56 | -0.56 | -0.55 | |||||
Mastitis($M) | -0.76 | -0.70 | -0.81 | -0.84 | -1.06 | -1.34 | -1.12 | -1.26 | |||||
Scours($M) | 2.81 | 3.35 | 2.82 | 1.59 | 1.23 | 2.30 | 1.24 | 1.26 | |||||
Corporate Segment, Scours($M) | 2.42 | 4.64 | 2.91 | 2.34 | 2.81 | 3.35 | 2.82 | 1.59 | |||||
Corporate Segment, Mastitis($M) | 0.01 | 0.02 | -0.00 | 0.02 | 0.01 | 0 | 0.02 | -0.00 | |||||
Mastitis($M) | 0.01 | 0 | 0.02 | -0.00 | -0.00 | -0.00 | 0.02 | 0.00 | |||||
Corporate Segment, Mastitis($M) | 0 | -0.01 | -0.06 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 | |||||
Corporate Segment, Scours($M) | -0.73 | -0.16 | -0.11 | -0.58 | -0.15 | -0.32 | -0.19 | -0.09 | |||||
Corporate Segment, Scours($M) | 37.5 | 36.9 | 38.2 | 26.0 | 38.2 | 24.5 | 24.6 | 23.7 | 24.7 | ||||
Corporate Segment, Mastitis($M) | 0.12 | 0.23 | 0.13 | 15.6 | 0.13 | 16.3 | 16.5 | 16.8 | 17.8 | ||||
Earlier reporting (last reported 2025)3 | |||||||||||||
8 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?